Interrogating the Mechanistic Link between Neighborhood Deprivation and Colorectal Cancer Risk through Transcriptomic Analysis of Normal Colorectal Biopsies
BACKGROUND: Greater neighborhood deprivation, as defined by the Neighborhood Deprivation Index (NDI), has been associated with increased colorectal cancer (CRC) risk. However, the biological mechanisms underlying this association remain unclear. METHODS: Normal colorectal biopsies (matched right and left colon, and rectum) from African Americans (AA; (n = 34)) and European Americans (EA; (n = 23)) adults undergoing colonoscopy were collected for a cross-sectional study in Cleveland, Ohio. NDI-associated differentially expressed genes (DEGs) were identified from RNA-sequencing (RNA-seq) using limma. Normal colon organoid lines were derived from biopsies of AA (n = 4) and EA (n = 6) individuals in Charlottesville, Virginia, treated daily with metformin for 72-hours, and metformin-DEGs were identified in limma. RESULTS: A total of 237 DEGs were found to be commonly associated with NDI in AA and EA populations across individual-matched biopsy triplets (right and left colon, and rectum). Of the 237 NDI-associated DEGs, 82 overlapped with CRC tumor DEGs from a publicly available dataset (P=2.21E⁻05), and nine were prioritized as therapeutic targets, including MYC overexpression (Benjamani Hochberg (BH)=2.48E-12). Metformin exposure in colon organoids also altered the expression of 28 of these genes, with ~79% showing opposite direction, including reduced MYC expression (BH=0.095). CONCLUSIONS: NDI is associated with CRC-related transcriptional differences. The observed reversal of gene expression by metformin, including at MYC, suggests a potential role for metformin in reducing CRC risk by modifying NDI-high related gene expression. IMPACT: NDI-associated CRC risk genes provide novel opportunity for future biomarkers or early therapeutic targets in at-risk populations.
Authors
- Seham Ebrahim (ORCID: https://orcid.org/0000-0002-6762-2432)
- Stephen Eaton (ORCID: https://orcid.org/0000-0002-9959-7518)
- Hania M. Taha (ORCID: https://orcid.org/0000-0003-4117-3314)
- Samyukta Venkatesh
- M Ishrat Ali
- Matthew A.M. Devall (ORCID: https://orcid.org/0000-0001-5943-4397)
- Cynthia Yoshida
- Stephanie L. Schmit (ORCID: https://orcid.org/0000-0001-5931-1194)
- Steven M. Powell (ORCID: https://orcid.org/0000-0002-2572-203X)
- Gaizun Hu (ORCID: https://orcid.org/0000-0002-1420-0789)
- Joseph Willis (ORCID: https://orcid.org/0000-0003-1782-886X)
- Xiangqing Sun (ORCID: https://orcid.org/0000-0003-3614-4682)
- Mackenzie Chen (ORCID: https://orcid.org/0009-0008-0842-4816)
- Alexa Ramirez (ORCID: https://orcid.org/0009-0008-4342-0853)
- Fatima Z. Habib (ORCID: https://orcid.org/0009-0007-8810-5243)
- Ulrike Peters (ORCID: https://orcid.org/0000-0001-5666-9318)
- Gregory S.. Cooper (ORCID: https://orcid.org/0000-0002-1673-440X)
Institutions
- Cleveland Clinic (US)
- University Hospitals of Cleveland (US)
- University of Virginia Health System (US)
- Cleveland Clinic Lerner College of Medicine (US)
- Fred Hutch Cancer Center (US)
- University of Virginia (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2026-04-14
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-1685
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Case Comprehensive Cancer Center, Case Western Reserve University
- National Cancer Institute